The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administration of a compound of formula A, wherein R is H, halo, or C1-C6 alkyl； R' is C1-C6 alkyl； or a pharmaceutically acceptable salt thereof； and optionally a pharmaceutically acceptable excipient.
